Alignment Healthcare, Inc. (ALHC) FinancialsALHCAlignment Healthcare, Inc.

Evaluating the bottom line, Alignment Healthcare, Inc. maintains a gross margin of 12.96%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 3.15%, while the net margin is 2.74%. These profitability ratios, combined with a Return on Equity (ROE) of 20.04%, provide a clear picture of how effectively ALHC converts its operational activities into shareholder value.

In the context of the broader market, ALHC competes directly with industry leaders such as OSCR and MOH. With a market capitalization of $1.51B, it holds a significant position in the sector. When comparing efficiency, ALHC's gross margin of 12.96% stands against OSCR's N/A and MOH's 11.96%. Such benchmarking helps identify whether Alignment Healthcare, Inc. is trading at a premium or discount relative to its financial performance.

The company has shown fluctuating revenue growth, with Q2 2026 revenue at $1.34 billion, but net income remains inconsistent, with a recent net income of $36.56 million in Q2 2026. Gross margin improved to 12.96% in Q2 2026, but the overall financial outlook remains uncertain due to recent downgrades.